BioCardia Announces Commercial Availability of Morph® DNA™ Steerable Introducer Product Family SUNNYVALE, Calif., Dec. 17, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

BioCardia Submits for FDA Approval of Morph® DNA™ Steerable Introducer Product Family BioCardia, Inc., today reported it has submitted a 510(k) for approval of its patented Morph® DNA™ Steerable Introducer Sheath with the FDA.